ETHICA
LIVE

Serial Number

78277322

Owner

ethica Clinical Research Inc.

Attorney

Dan S. Cohn

First Use Date

Sep 1, 2002

Filing Date

Jul 22, 2003

Add to watchlist:

No watchlists yet
View on USPTO

ETHICA Trademark

Serial Number: 78277322 • Registration: 3188634

ETHICA is a trademark filed by ethica Clinical Research Inc. on July 22, 2003. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

ethica Clinical Research Inc. (2 trademarks)

8555 Transcanada Highway
Montreal, Quebec H4S1Z6 , CA

Entity Type: 03

ETHICA CRO INC. (2 trademarks)

3551 SAINT-CHARLES BLVD.
KIRKLAND, QUEBEC H9H 3C4 , CA

Entity Type: 03

Trademark Details

Filing Date

July 22, 2003

Registration Date

December 26, 2006

First Use Anywhere

September 1, 2002

First Use in Commerce

September 1, 2002

Published for Opposition

October 10, 2006

Goods & Services

Clinical trial supplies management services, namely-customized drug packaging and labeling, central and site administered randomization and study supply distribution; developing and managing distribution and storage logistics for all clinical supplies, namely study drugs and devices, case report forms, study binders and all study related documentation; clinical trial management services, namely-pre-study document collection and review, site selection, pre-study site visits, initiation visits, monitoring visits, close-out visits, project tracking and monitoring reports, negotiation and administration of investigator grants, labeling, packaging, distribution, coordination and tracking of clinical trial materials, regulatory document processing, central laboratory selection and coordination; managing site and study-specific subject recruitment strategies and programs, namely contingency strategies and solutions to address specific project challenges; managing the development of all study related documents and materials, namely study protocols, amendments, paper and electronic case report forms, and informed consent forms; managing study operations/monitoring manuals in accordance with data management conventions, web-based data listings, namely adverse events, enrollment status, efficacy endpoints and paper and electronic study newsletters; management of tracking tools for enrollment, essential documents, monitoring, subject and case report form tracking, drug accountability, data queries and adverse events; managing all aspects of study drug reconciliation and inventory and distribution reports; managing all aspects of clinical trials, namely managing investigators, technicians, and participants, ethical reviews, investigator meetings, databases, statistical analyses and reporting, randomization logistics, medical writing services; recruitment of investigators, technicians and participants; providing strategies for recruitment of participants

Research services for clinical trials for others, namely conducting an ethical review of projects to protect the rights and welfare of research participants, developing study protocols, designing case report forms, developing participant screening tools, namely general and medical questionnaires, developing complete databases in accordance with strict guidelines, tracking of study parameters, providing statistical analyses, reporting and developing tracking tools for enrollment, essential documents, monitoring, subject and case report form tracking, drug accountability, data queries and adverse events; developing and implementing randomization logistics, namely randomization envelopes, customized blind-breakable drug labeling, code break management and reports, manufacturing of subject-and protocol-specific kits using bulk oral and topical medications; medical writing services, namely-drafting clinical study protocols, amendments, case report forms, informed consent forms, statistical analysis plans, full integrated clinical research reports, publications, abstracts and manuscript; developing site and study-specific subject recruitment strategies and programs, namely contingency strategies and solutions to address specific project challenges; developing study operations and monitoring manuals in accordance with data management conventions, web-based data listings, namely adverse events, enrollment status, efficacy endpoints and paper and electronic study newsletters

Study specific clinical personnel training programs for investigators, coordinators and investigator meetings; conducting investigator meetings

Filing History

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Dec 26, 2025 REM2
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Sep 20, 2023 ASGN
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Feb 23, 2017 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Feb 23, 2017 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Feb 23, 2017 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 23, 2017 APRE
TEAS SECTION 8 & 9 RECEIVED
Dec 22, 2016 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Dec 26, 2015 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jan 16, 2013 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jan 15, 2013 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 15, 2013 APRE
TEAS SECTION 8 & 15 RECEIVED
Dec 20, 2012 E815
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 23, 2009 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 23, 2009 COAR
EXPARTE APPEAL TERMINATED
Jan 29, 2007 EXPT
REGISTERED-PRINCIPAL REGISTER
Dec 26, 2006 R.PR
PUBLISHED FOR OPPOSITION
Oct 10, 2006 PUBO
NOTICE OF PUBLICATION
Sep 20, 2006 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 18, 2006 PREV
ASSIGNED TO LIE
Aug 11, 2006 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 1, 2006 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 12, 2006 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 13, 2006 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 13, 2006 TROA
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
May 15, 2006 GEAP
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
May 15, 2006 CPEA
ACTION DENYING REQ FOR RECON E-MAILED
Feb 15, 2006 GECD
ACTION CONTINUING FINAL - COMPLETED
Feb 15, 2006 CNCF
EX PARTE APPEAL-INSTITUTED
Dec 28, 2005 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Dec 28, 2005 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Dec 22, 2005 EXAF
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 21, 2005 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 13, 2005 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 13, 2005 TROA
FINAL REFUSAL E-MAILED
Jun 13, 2005 GNFR
FINAL REFUSAL WRITTEN
Jun 13, 2005 CNFR
USE AMENDMENT ACCEPTED
May 20, 2005 IUAA
AMENDMENT FROM APPLICANT ENTERED
May 18, 2005 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 29, 2005 CRFA
FAX RECEIVED
Apr 29, 2005 FAXX
INQUIRY TO SUSPENSION E-MAILED
Apr 11, 2005 GNSI
SUSPENSION INQUIRY WRITTEN
Apr 11, 2005 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Mar 10, 2005 RCCK
LETTER OF SUSPENSION E-MAILED
Sep 9, 2004 GNSL
SUSPENSION LETTER WRITTEN
Sep 9, 2004 CNSL
AMENDMENT FROM APPLICANT ENTERED
Aug 12, 2004 ACEC
ASSIGNED TO LIE
Aug 12, 2004 ALIE
AMENDMENT FROM APPLICANT ENTERED
Aug 9, 2004 ACEC
ASSIGNED TO LIE
Aug 9, 2004 ALIE
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 30, 2004 CRFA
PAPER RECEIVED
Jul 30, 2004 MAIL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 26, 2004 CRFA
NON-FINAL ACTION E-MAILED
Jan 27, 2004 GNRT
ASSIGNED TO EXAMINER
Jan 12, 2004 DOCK
AMENDMENT TO USE PROCESSING COMPLETE
Sep 17, 2003 AUPC
USE AMENDMENT FILED
Sep 10, 2003 IUAF
TEAS AMENDMENT OF USE RECEIVED
Sep 10, 2003 EAAU